News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Opinion Editor's Corner ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness Shelley Wood August 24, 2016
News Daily News Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI L.A. McKeown August 17, 2016
News Daily News Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI L.A. McKeown August 17, 2016
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Daily News El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI L.A. McKeown August 11, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Daily News Interactive Smartphone App Can Motivate MI Patients to Take Their Meds Caitlin E. Cox June 06, 2016
News Daily News Ticagrelor Doesn’t Beat Aspirin for Secondary Prevention After Stroke-TIA: SOCRATES Todd Neale May 11, 2016
News Daily News SOCRATES: Ticagrelor No Supera a la Aspirina en Prevención Secundaria Post ACV-AIT Todd Neale May 11, 2016
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Daily News Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES Yael L. Maxwell March 30, 2016
News Daily News Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF Yael L. Maxwell March 30, 2016
News Daily News Crushed Prasugrel Pills Beat Whole Tablets for Controlling Platelets During Primary PCI Caitlin E. Cox March 28, 2016
News Daily News Análisis del Ensayo GRAVITAS: La ‘Paradoja del Fumador’ Desaparece con Dosis Dobles de Clopidogrel Michael O'Riordan February 28, 2016
News Daily News ‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis Michael O'Riordan February 28, 2016
News Industry News Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack February 18, 2016
Presentation Ticagrelor vs Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI Presenter: Dominick J. Angiolillo February 09, 2016